Everything Totally Explained


Ask & we'll explain, totally!
Platelet-activating factor
Totally Explained


  NEW! All the latest news in the worlds of computer gaming, entertainment, the environment,  
finance, health, politics, science, stocks & shares, technology and much, much, more.  


View this entry using RSS

Everything about Platelet-activating Factor totally explained

| Section2 = | Section3 = }} Platelet-activating factor, also known as a PAF, PAF-acether or AGEPC (acetyl-glyceryl-ether-phosphorylcholine) is a potent phospholipid activator and mediator of many leukocyte functions, including platelet aggregation, inflammation, and anaphylaxis.
   It is produced in response to specific stimuli by a variety of cell types, including neutrophils, basophils, platelets, and endothelial cells.

Chemistry

Several molecular species of platelet-activating factor have been identified which vary in the length of the O-alkyl side chain.
  • Its alkyl group is connected by an ether linkage at the C1 carbon to a sixteen carbon chain.
  • The acyl group at the C2 carbon is an acetate unit (as opposed to a fatty acid) whose short length increases the solubility of PAF, allowing it to function as a soluble signal messenger.
  • The C3 has a phosphocholine head group, just like standard phosphatidylcholine.

Function

It is an important mediator of bronchoconstriction.
   It causes platelets to aggregate and blood vessels to dilate. At a concentration of 10^-12 M, PAF causes life threatening inflammation of the airways to induce asthma like symptoms. Toxins such as fragments of destroyed bacteria induce the synthesis of PAF, which causes a drop in blood pressure and reduced volume of blood pumped by the heart, which leads to shock and maybe death.

History

It was discovered by French immunologist Jacques Benveniste in the early 1970s. Its structure was elucidated by Constantinos A. Demopoulos in 1979.

Biosynthesis and degradation

PAF is biosynthesized from lysophosphatidylcholine (LPC) and acetyl CoA by the enzyme LPC acetyltransferase (LPCAT).
   It is degraded (thereby terminating its capacity to act as a signaling molecule) by a group of enzymes called PAF acetylhydrolases (PAFAHs) which are related to phospholipase A2.

Antagonists

  • SM-12502 is a PAF antagonist, which is metabolized in the liver by the enzyme CYP2A6. Further Information

    Get more info on 'Platelet-activating Factor'.


    External Link Exchanges

    Do you know how hard it is to get a link from a large encyclopaedia? Well we're different and will prove it. To get a link from us just add the following HTML to your site on a relevant page:

      <a href="http://platelet-activating_factor.totallyexplained.com">Platelet-activating factor Totally Explained</a>

    Then simply click through this link from your web page. Our crawlers will verify your link, extract the title of your web page and instantly add a link back to it. If you like you can remove the words Totally Explained and embed the link in article text.
       As long as your link remains in place, we'll keep our link to you right here. Please play fair - our crawlers are watching. Your site must be closely related to this one's topic. Any kind of spamming, dubious practises or removing the link will result in your link from us being dropped and, potentially, your whole site being banned.



  • Copyright © 2007-8 totallyexplained.com | Licensed under the GNU Free Documentation License | Site Map
    This article contains text from the Wikipedia article Platelet-activating factor (History) and is released under the GFDL | RSS Version